Procept BioRobotics Corp’s recent filing unveils that its EVP, CFO Waters Kevin unloaded Company’s shares for reported $2.06 million on Sep 16 ’24. In the deal valued at $82.51 per share,25,000 shares were sold. As a result of this transaction, Waters Kevin now holds 96,096 shares worth roughly $6.69 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Kevin Waters bought 50,000 shares, generating $4,055,500 in total proceeds.
Before that, Desai Antal Rohit sold 44,867 shares. Procept BioRobotics Corp shares valued at $3,594,377 were divested by the Director at a price of $80.11 per share. As a result of the transaction, Desai Antal Rohit now holds 197,453 shares, worth roughly $13.75 million.
Piper Sandler initiated its Procept BioRobotics Corp [PRCT] rating to an Overweight in a research note published on August 11, 2023; the price target was $42. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in late May with a ‘”an Outperform”‘ rating. BTIG Research began covering PRCT with “Neutral” recommendation on October 31, 2022. Truist started covering the stock on October 25, 2022. It rated PRCT as “a Buy”.
Price Performance Review of PRCT
On Monday, Procept BioRobotics Corp [NASDAQ:PRCT] saw its stock fall -4.18% to $69.62. Over the last five days, the stock has lost -13.11%. Procept BioRobotics Corp shares have risen nearly 66.12% since the year began. Nevertheless, the stocks have risen 132.84% over the past one year. While a 52-week high of $85.81 was reached on 08/21/24, a 52-week low of $24.83 was recorded on 01/05/24. SMA at 50 days reached $73.10, while 200 days put it at $59.30.
Levels Of Support And Resistance For PRCT Stock
The 24-hour chart illustrates a support level at 68.27, which if violated will result in even more drops to 66.92. On the upside, there is a resistance level at 71.89. A further resistance level may holdings at 74.16. The Relative Strength Index (RSI) on the 14-day chart is 33.94, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -6.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.36%. Stochastics %K at 4.15% indicates the stock is a buying.
How much short interest is there in Procept BioRobotics Corp?
A steep rise in short interest was recorded in Procept BioRobotics Corp stocks on 2024-09-13, growing by 24272.0 shares to a total of 5.7 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 5.67 million shares. There was a rise of 0.43%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 02, 2022 when Wells Fargo began covering the stock and recommended ‘”an Overweight”‘ rating along with a $49 price target.
